John Lee

John Lee, MD

Assistant in Medicine; Director, Food Allergy Program; Co-Director, Eosinophilic Gastrointestinal Disease (EGID) Program

Instructor in Pediatrics, Harvard Medical School

    Contact: 617-355-6117
  • Fax: 617-730-0310

Medical Services

Specialties

  • Immunotherapy
  • Drug Allergy
  • Eczema
  • Eosinophilic Diseases of Gastrointestinal Tract
  • Allergic Gastrointestinal Disorders
  • Anaphylaxis
  • Atopic Dermatitis
  • Recurrent Infections
  • Food Allergy
  • Allergy Immunology
  • Asthma

Departments

  • Allergy Immunology

Programs

  • Center for Airway Disorders (CAD)
  • Eosinophilic Gastrointestinal Disease Program
  • Primary Immunodeficiency Disorders Program
  • Allergy Program
To schedule an appointment: Call 617-355-6117 or Request an Appointment

Experience and Education

Education

Undergraduate

Yale University,

New Haven, CT

Medical School

New York University School of Medicine,

New York, NY

Fellowship

Allergy/Immunology - Boston Children's Hospital,

Boston, MA

Internship

Pediatrics - Children's Hospital of Philadelphia,

Philadelphia, PA

Pediatrics

Columbia-Presbyterian Children's Hospital,

New York, NY

Publications

Publications powered by Harvard Catalyst Profiles
  1. Pistiner M, Lee JJ. Creating a new community of support for students with food allergies. NASN Sch Nurse. 2012 Sep; 27(5):260-6.
  2. Lee JJ, Rauter I, Garibyan L, Ozcan E, Sannikova T, Dillon SR, Cruz AC, Siegel RM, Bram R, Jabara H, Geha RS. The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function. Blood. 2009 Sep 10; 114(11):2254-62.
  3. Lee JJ, Ozcan E, Rauter I, Geha RS. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency. Curr Opin Allergy Clin Immunol. 2008 Dec; 8(6):520-6.
  4. John Lee. Children's Hospital Profile.
  5. Ozcan E, Garibyan L, Lee JJ, Bram RJ, Lam KP, Geha RS. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells. J Allergy Clin Immunol. 2009 Jun; 123(6):1277-86.e5.
  6. Lee JJ, Jabara HH, Garibyan L, Rauter I, Sannikova T, Dillon SR, Bram R, Geha RS. The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency. J Allergy Clin Immunol. 2010 Dec; 126(6):1234-41.e2.
  7. Rubinstein E, Lee JJ, Fried A, Logvinenko T, Ngo P, McDonald D, Hait EJ. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr. 2014 Sep; 59(3):317-20.
To schedule an appointment: Call 617-355-6117 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close